MiMedx Group (MDXG) Rating Lowered to Hold at BidaskClub
MiMedx Group (NASDAQ:MDXG) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.
MDXG has been the topic of a number of other research reports. Piper Jaffray Companies reaffirmed a “buy” rating and set a $18.00 price target on shares of MiMedx Group in a report on Friday, November 24th. Needham & Company LLC reaffirmed a “buy” rating and set a $21.00 price target on shares of MiMedx Group in a report on Tuesday, November 14th. Lake Street Capital set a $18.00 price target on shares of MiMedx Group and gave the company a “buy” rating in a report on Thursday, December 14th. Finally, Zacks Investment Research downgraded shares of MiMedx Group from a “hold” rating to a “sell” rating in a report on Friday, December 8th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $15.50.
Shares of MiMedx Group (NASDAQ MDXG) traded down $5.72 during midday trading on Wednesday, hitting $8.75. 21,794,502 shares of the stock were exchanged, compared to its average volume of 2,526,451. The stock has a market cap of $1,606.68, a P/E ratio of 28.23, a PEG ratio of 1.88 and a beta of 1.08. MiMedx Group has a 12-month low of $7.70 and a 12-month high of $18.25.
Institutional investors and hedge funds have recently bought and sold shares of the stock. GABELLI & Co INVESTMENT ADVISERS INC. purchased a new position in shares of MiMedx Group in the third quarter worth approximately $119,000. BlueCrest Capital Management Ltd purchased a new position in shares of MiMedx Group in the fourth quarter worth approximately $126,000. PVG Asset Management Corp purchased a new position in shares of MiMedx Group in the third quarter worth approximately $127,000. Ameritas Investment Partners Inc. boosted its holdings in shares of MiMedx Group by 7.5% in the second quarter. Ameritas Investment Partners Inc. now owns 8,619 shares of the medical equipment provider’s stock worth $129,000 after buying an additional 600 shares during the last quarter. Finally, Ladenburg Thalmann Financial Services Inc. raised its stake in MiMedx Group by 6,262.5% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 12,725 shares of the medical equipment provider’s stock worth $151,000 after acquiring an additional 12,525 shares during the period. 71.15% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/mimedx-group-mdxg-rating-lowered-to-hold-at-bidaskclub/1880010.html.
MiMedx Group Company Profile
MiMedx Group, Inc is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.
Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.